USD10
ABSI Shares
About AbsciAbsci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
USD10
ABSI Shares
About AbsciAbsci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
Stats
TRADING WINDOW
Open
CLOSES AT
8:00 PM UTC
MARKET CAP
$1.4B
OPEN PRICE
$8.93
LOW (1Y)
$2.24
HIGH (1Y)
$12.06
LOW (24H)
$8.12
HIGH (24H)
$8.95
VOLUME (24H)
$2.59M
28.72%
Price history
Time | Price | Change |
|---|---|---|
Today | $8.93 | |
1 Day | $8.88 | |
1 Week | $10.26 | |
1 Month | $8.02 | |
1 Year | $4.53 |
Past performance is not a reliable indicator of future results.
Discover more
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.